Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016 (2016), Article ID 4827268, 12 pages
http://dx.doi.org/10.1155/2016/4827268
Review Article

Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes

1Department of Neuroscience, Karolinska Institutet, Retzius väg 8. 17177 Stockholm, Sweden
2Department of Biomolecular Science, Section of Physiology, University of Urbino, Campus Scientifico Enrico Mattei, Via Ca’ le Suore 2, I-61029 Urbino, Italy
3Observatorio Cubanos de Neurociencias, Grupo Bohío-Estudio, Yaguajay, Cuba
4Laboratory of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Street, PL-31-343 Kraków, Poland
5Institute of Biomedicine and Translational Medicine, Department of Physiology, University of Tartu, 19 Ravila Street, 50411 Tartu, Estonia
6Universidad de Málaga, Instituto de Investigación Biomédica de Málaga, Facultad de Medicina, Málaga, Spain
7Centro Nacional de Neurociencias, La Habana, Cuba
8Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
9Centro de Investigaciones en Red, Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
10Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
11Department of Medical Sciences, University of Ferrara, Ferrara, Italy

Received 22 January 2016; Revised 28 August 2016; Accepted 3 October 2016

Academic Editor: Lin Xu

Copyright © 2016 Dasiel O. Borroto-Escuela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Our hypothesis is that allosteric receptor-receptor interactions in homo- and heteroreceptor complexes may form the molecular basis of learning and memory. This principle is illustrated by showing how cocaine abuse can alter the adenosine A2AR-dopamine D2R heterocomplexes and their receptor-receptor interactions and hereby induce neural plasticity in the basal ganglia. Studies with A2AR ligands using cocaine self-administration procedures indicate that antagonistic allosteric A2AR-D2R heterocomplexes of the ventral striatopallidal GABA antireward pathway play a significant role in reducing cocaine induced reward, motivation, and cocaine seeking. Anticocaine actions of A2AR agonists can also be produced at A2AR homocomplexes in these antireward neurons, actions in which are independent of D2R signaling. At the A2AR-D2R heterocomplex, they are dependent on the strength of the antagonistic allosteric A2AR-D2R interaction and the number of A2AR-D2R and A2AR-D2R-sigma1R heterocomplexes present in the ventral striatopallidal GABA neurons. It involves a differential cocaine-induced increase in sigma1Rs in the ventral versus the dorsal striatum. In contrast, the allosteric brake on the D2R protomer signaling in the A2AR-D2R heterocomplex of the dorsal striatopallidal GABA neurons is lost upon cocaine self-administration. This is potentially due to differences in composition and allosteric plasticity of these complexes versus those in the ventral striatopallidal neurons.

1. Introduction

The receptor-receptor interaction field began with the studies on neuropeptide-monoamine receptor-receptor interactions in brain membrane preparations which altered especially the affinity of the monoamine receptor subtypes [1, 2]. The aim of the study was to understand the integration of peptide and monoamine signals present in many neuronal networks of the Central Nervous System (CNS). It was proposed that they took place in postulated heteroreceptor complexes in the plasma membrane [3]. In these complexes, adaptor proteins can participate and higher-order homo- and heteroreceptor complexes can also exist in which allosteric receptor-receptor interactions operate [48]. We call them hetero- or homoreceptor complexes since a number of other proteins also participate like adaptor proteins which can directly bind to the receptor protomers undergoing homomerization or heteromerization [813].

These integrative mechanisms give sophisticated dynamics to the structure and function of the heteroreceptor complexes with regard to alterations of recognition, signaling, and trafficking of the receptor protomers. Due to allosteric receptor-receptor interactions, increased diversity and selectivity develop in receptor pharmacology and function [19, 20]. Dynamics is also given to the heteroreceptor complex through its balance with the corresponding homoreceptor complexes and other types of heteroreceptor complexes which share one or more receptor protomers [8, 10, 11].

It is of high interest to understand the role of the allosteric receptor-receptor interactions in heteroreceptor complexes in neurons, brain circuits, and at the global network level. In the current paper, we will discuss how this novel biological principle can serve to modulate the plasticity and function of the neural-glial networks of the CNS. The major focus will be on how cocaine abuse in rats can alter the adenosine A2A receptor- (A2AR-) dopamine D2 receptor (D2R) heterocomplexes and their receptor-receptor interactions in the neural-glial networks of the basal ganglia [12, 21].

2. Integration of Volume Transmission and Synaptic Transmission in the Neural-Glial Networks of the CNS through Receptor-Receptor Interactions in Heteroreceptor Complexes

The G protein-coupled receptor (GPCR) heterocomplex concept includes not only GPCR-GPCR heterocomplexes but also the interactions between GPCR and other membrane receptors, for instance, the ion channel receptors or receptor tyrosine kinases (RTK) heterocomplexes [9, 2229]. GPCRs with high affinity for neurotransmitters are major receptors for volume transmission (VT) and ion channel receptors like NMDA, AMPA, and GABA receptors are major receptors for synaptic transmission. Therefore, GPCR-ion channel receptor heterocomplexes are major integrators of VT and synaptic transmission in neural-glial networks [30, 31]. This integration, which takes place at both the prejunctional and postjunctional level, can up- or downregulate synaptic efficacy and thus synaptic strength within neural-glial networks. The VT signals may originate, for example, from local glial cells, extrasynaptic release of transmitters from neural afferents, local collaterals, and soma-dendrites and from diffusion and flow of for example, neuropeptides, and proteins or of extracellular vesicles from cerebrospinal fluids and/or surrounding neural-glial networks also forming functional modules. This major mechanism for the balance and integration of synaptic and volume transmission may then lead to changes in the preferred outputs from the neural-glial module which in turn will change the function in the brain circuit involved.

Instead, GPCR-RTK heterocomplexes are of relevance for the survival and repair of the neural-glial networks by integrating and balancing trophic signaling with the GPCR-mediated metabolic signaling and information handling [32]. Relevant examples of direct GPCR-RTK receptor-receptor interactions are A2AR-FGFR1 [25, 33], 5-HT1A-FGFR1 [9, 27, 28], M3R-FGFR1 [34], TGR5-EGFR [35], and ADRB2-INR heteroreceptor complexes [36]. Wiese et al. [37] and Assaife-Lopes et al. [38] demonstrated transactivation mechanisms between adenosine A2A receptor and TrkB receptor, which can involve allosteric mechanisms via direct GPCR-RTK interactions.

The changes in the protomer signaling panorama within the heteroreceptor complex may be highly dynamic processes related to the transient nature of the receptor complexes formed and can represent learning if by repetition it leads to short-term memory (see below) [13, 31].

3. Understanding the Molecular Basis of Learning and Memory through Allosteric Receptor-Receptor Interactions in Multiple Homo- and Heteroreceptor Complexes in Neuronal Networks

Changes in synaptic efficacies via alterations in synaptic strength are regarded as fundamental to learning [39]. The theory was recently advanced that such changes in synaptic plasticity can be brought about by anatomical reorganization of multiple postsynaptic homo- and heteroreceptor complexes and by resetting the multiple allosteric receptor-receptor interactions according to the patterns and amounts of synaptic signals released from the synaptic terminals decoded from the arriving patterns of action potentials [13, 31]. Such a molecular reorganization of the receptor-protein architecture of the entire postsynaptic membrane is proposed to be the molecular basis of learning and short-term memory. It may be described as a change of the barcode in the individual synapse, which leads to the formation of a new molecular engram. According to the theory, a reorganization of presynaptic homo- and heteroreceptor complexes also developed in the learning and memory process in order to ensure the maintenance of the pattern and amounts of multiple transmitters and modulators released which must be sensed by the postsynaptic membrane (Figure 1).

Figure 1: Illustration of possible reorganization of the homo- and heteroreceptor complexes within the synaptic and extrasynaptic regions of the glutamate synapses of the striatopallidal GABA neurons in the learning process. The receptor monomers are not illustrated. The left panel represents the basal state and the right panel the state that has developed in the learning process. They can become stabilized into a long lasting receptor assemblies through the formation of novel adaptor and scaffolding proteins. If so, they will represent short-term memory that can be converted into long-term memory through further consolidation.

Previous work discussed how GPCR modulates the kinetics of G protein signaling [40]. The signaling dynamics of 5-HT1A-FGFR1 and D2-NTS1 heteroreceptor complexes were also reported [26, 41]. Oligomer size of diffusing GPCRs in the plasma membrane can be determined by fluorescence correlation spectroscopy with photon counting histogram analysis and the 5-HT2C receptor diffused as a dimer [42]. Single fluorescent-molecule imaging demonstrates dynamic GPCR dimerization using a chemoattractant GPCR, the N-fomyl peptide receptor (FPR) [43]. A number of cycles of monomer and homodimer formation take place over one second. Thus, FPR dimers are quickly formed from FPR monomers and FPR monomers are rapidly formed from rapid dissociation of the FPR dimers [44]. Experimental studies support the view that the dynamic properties of GPCRs depend on their coupling to the membrane environment, where the lipid composition plays a role in ligand-induced properties [45]. The dynamics are also indicated from studies using spatial intensity distribution analysis [46] and RT-BRET to understand the oligomeric organization of GPCRs [26]. The analysis demonstrated multiple forms from monomers to higher-order oligomers of the GPCR studied.

These studies support our view that the dynamic panorama of homo- and heteroreceptor complexes and their stabilization can form the basis of learning and memory at the molecular level and represent the molecular engram, when consolidated (Figure 1).

Our hypothesis on the molecular basis of learning and memory is summarized as follows:(i)Learning requires a new temporal qualitative and quantitative pattern of release of neurotransmitters. The transient reorganization of the homo- and heteroreceptor complexes in the postsynaptic membrane contributes to pattern formation.(ii)This molecular reorganization of the postsynaptic membrane leads to a novel barcode, which represents a short-term memory (transient molecular engram) and defines the new pattern of transmitter release.(iii)This memory process is facilitated by the reorganization also of the presynaptic receptor complexes to help maintain the new transmitter release pattern to be learned by the postsynaptic membrane. Thus, the altered transmitter panorama can change the formation or disrupt the presynaptic receptor complexes through agonist dependent processes. A retrograde feedback from the new postsynaptic transient molecular engram can also assist in this process. It can involve the release and diffusion of soluble factors like purines and trophic factors and of extracellular vesicles like exosomes and microvesicles containing proteins including receptors and lipids.(iv)The consolidated reorganization of the postsynaptic receptor complexes and their extrasynaptic regions, including changes in scaffold proteins like Disc1 and SHANK, can lead to long-term memory. The long-term memory should result in a barcode and molecular engram similar to one found in short-term memory. The mechanism for this process may involve the transformation of parts of the heteroreceptor complexes into unique transcription factors which can lead to the formation of novel adaptor proteins like GPCR interacting proteins and receptor activity-modifying proteins. Some of these proteins can link the heteroreceptor complexes more strongly together. Others can link the heteroreceptor complexes more strongly to the cytoskeleton and to scaffold proteins and synaptic cell adhesion molecules.(v)Of special interest for the formation of truly long-term molecular engrams may be the release of transmitters from close-by terminals belonging to emotional brain circuits using, for example, dopamine (DA) as a transmitter [31]. When such terminal networks are activated due to motivation and reward linked to the learning and memory process, the transmitter, for example, DA, can interact with the synapse, where the molecular engram is being formed, through short distance volume transmission. It is postulated that the activation of, for example, synaptic and extrasynaptic DA heteroreceptor complexes on the postsynaptic side has an ability via unique transcription factors to produce special adaptor proteins that can bind to the receptor-protein architecture of the molecular engram and consolidate them with an exceptional efficacy leading to life-long memories.

4. On the Role of Antagonistic A2A-D2 Allosteric Receptor-Receptor Interactions in Heteroreceptor Complexes for Neuronal Plasticity: Studies in Cocaine Use Disorder Models

It was early on observed that the adenosine A2AR agonist CGS 21680 reduced the affinity of the dopamine D2R agonist binding sites, especially in the high affinity state, in dorsal striatum and nucleus accumbens [47, 48]. Thus, antagonistic A2AR-D2R interactions appear to exist in the plasma membrane of neurons. It was further demonstrated that the A2ARs and D2Rs coaggregate, cointernalize, and codesensitize in heteroreceptor complexes [49]. In line with these findings, agonist activation of the A2AR protomer in the A2AR-D2R heteroreceptor complexes reduces D2R Gi/o-mediated signaling through the allosteric receptor-receptor interaction [19, 50]. Instead, the A2AR agonist increases the D2R beta-arrestin2 mediated signaling and can be characterized as a biased inhibitory modulator of the Gi/o-mediated D2R signaling [51]. This action may explain its atypical antipsychotic activities [50, 52].

The A2AR-D2R heterocomplexes interface involves mainly intracellular domains where electrostatic interactions form clasps in the interface (hot spots) [5355] and transmembrane domains [56] where triplet amino acid homologies can play a special role as adhesive guides in the formation of the heteromer [57].

The overall architecture of the global GPCR heterodimer network (http://www.gpcr-hetnet.com/) [58] demonstrates that both A2ARs and D2Rs are hub components, each able to interact with ten or more different GPCRs. Thus, the A2AR-D2R heteroreceptor complex in a neuron can be in a complex balance not only with A2AR and D2R homoreceptor complexes but also with other types of A2AR and D2R heteroreceptor complexes, respectively [8, 10, 11].

The A2AR-DR2 heteroreceptor complexes were demonstrated in the dorsal and ventral striatum by means of the proximity ligation assay (in situ PLA) [34, 59]. In relation to cocaine use disorder, it is of substantial interest that these complexes may participate in postjunctional mesolimbic DA transmission in the nucleus accumbens core and shell in view of their presence in high densities in these two regions.

In situ PLA-positive A2AR-D2R heteroreceptor complexes are visualized in striatal sections as red clusters (blobs, puncta) within different regions of the neuropil of caudate putamen and nucleus accumbens core and shell, which can be quantitated as, for example, average number of blobs/cell [34].

4.1. Ventral Striatopallidal GABA Neurons

A2AR-D2R heteroreceptor complexes exist mainly in the ventral striatopallidal GABA neurons that mediate antireward [60]. The circuit continues from the ventral pallidum into the medial thalamic nucleus-prefrontal cortex as well as into the ventral midbrain, there mainly appearing as collaterals from the other regions [61]. The stoichiometry of these complexes is unknown but can involve heterotrimers, heterotetramers, and etcetera. Also the critical balance with other types of A2AR or D2R heteroreceptor complexes is unknown [11]. One ventral striatopallidal GABA neuron may differ from another one with regard to the stoichiometry and composition of the A2AR-D2R heteroreceptor complexes as well as their distribution pattern among synapses. Does each neuron of this pathway possess a unique distribution of A2AR-D2R heteroreceptor complexes to certain of its synapses while others lack these complexes? Can the switching in the balance between different D2R and A2AR heteroreceptor complexes in the same synapse be part of the learning process and contribute to short term and, if relevant, long-term memory and thus to the formation of a molecular engram (see above)? It is also of special interest that a loss of TrkB, the receptor for BDNF, in D2R positive accumbens neurons leads to increased neuronal excitability and suppression of reward [60]. These results open up the possibility that TrkB-D2R heteroreceptor complexes exist in which TrkB directly or indirectly make the inhibitory Gi/o-mediated D2R signaling possible, which leads to hyperpolarization and reduced excitability and firing. Thus, it appears possible that A2AR-D2R-TrkB heteroreceptor complexes can also exist in this antireward system. In fact, it was found that A2ARs are necessary for the baseline BDNF levels and for enhancement of synaptic transmission by BDNF as determined in the hippocampus [62].

4.2. Pharmacological Studies with Cocaine Self-Administration Procedures

We have studied the effects of the A2AR agonist CGS 21680 on cocaine self-administration under different schedules of reinforcement. Active lever presses and cocaine infusions were attenuated by CGS 21680 [63] and these effects could not be explained by sedation and reduction in locomotion although such inhibitory motor actions are linked to A2AR activation [63]. These results clearly indicated that activation of A2ARs inhibits cocaine-induced reward in agreement with previous work [21, 64]. Of substantial interest were the inhibitory effects of the CGS 21680 treatment in a progressive ratio schedule of reinforcement protocol with a 4-hour breaking point [63] indicating that A2AR stimulation brings down not only cocaine reward but also cocaine motivation.

A neurochemical correlate was also obtained. The effects of an accumbal perfusion of CGS 21680 were studied on changes induced by a 2 h cocaine self-administration session on extracellular accumbal DA, GABA, and glutamate levels. In the cocaine self-administration session over 2 h, CGS 21680 induced an increase in extracellular GABA levels which appeared to reduce the increase in extracellular DA levels found during cocaine self-administration [63]. This mechanism may restore the glutamate drive to the prefrontal cortex from the dorsomedial thalamic nucleus [50] helping the prefrontal cortex to restore its control of the accumbens reward system. These results are compatible with the involvement of antagonistic allosteric A2AR-D2R interactions in the ventral striatopallidal antireward system in mediating the A2AR induced inhibition of cocaine reward [63]. Thus, restoring the allosteric antagonistic plasticity in the neuronal A2AR-D2R heteroreceptor complex may contribute to anticocaine actions of A2AR agonists.

Such an increase in antagonistic allosteric plasticity in the A2AR-D2R heteroreceptor complex can also help explain why the A2AR agonist CGS 21680 produced a dose-dependent blockade of the cocaine, quinpirole, and cue-induced reinstatement of cocaine seeking [65, 66]. In support of the view that the antagonistic A2AR-D2R interactions may control drug seeking, it was found that CGS 21680 was 4 times more powerful in counteracting the D2-like receptor agonist quinpirole-induced relapse versus cocaine-induced relapse.

These inhibitory actions of CGS 21680 towards cocaine- or quinpirole-induced reinstatement of cocaine seeking behaviors in rats were in line with previous studies using i.p. injections or intra-accumbal infusions with the A2AR agonist [67]. CGS 21680 also blocked cue-induced food seeking [65]. It is of relevance to point out that there exist also targets in the nucleus accumbens for A2AR agonists other than the A2AR-D2R heteroreceptor complexes like the A1-A2A heteroreceptor complexes preferentially located on the corticostriatal glutamate terminals [68, 69]. Here, A2AR agonists can enhance glutamate release inter alia by an antagonistic allosteric receptor-receptor interaction with the A1R protomer which reduces its brake on glutamate release, which can modulate the activity of the D2R positive antireward and D1R positive reward neurons. Furthermore, there is evidence for the existence of postjunctional A2AR-mGlu5R and A2AR-D2R-mGlu5R heteroreceptor complexes in the striatopallidal GABA neurons [69, 70] where the mGlu5R protomer synergizes with the A2AR protomer to reduce D2R protomer signaling and its inhibition of the striatopallidal GABA neurons [71]. By targeting also these heterocomplexes, the anticocaine actions of A2AR agonists can become amplified.

It is also possible that these two types of A2AR-mGlu5R heteroreceptor complexes exist in the glutamate nerve terminals where the A2ARs and mGlu5Rs colocalize and functionally interact in synergistically enhancing glutamate release [72]. It appears that A2AR agonists by targeting several A2AR heteroreceptor complexes and A2AR homoreceptor complexes in the nucleus accumbens can increase activity in the antireward GABA neurons leading to anticocaine actions. It was proposed that A2AR participates in a mechanism to integrate the GABA, DA, and glutamate signaling [73]. In this mechanism, also A2AR homoreceptor complexes participate and can inter alia be involved at the presynaptic level in increasing the synaptic striatopallidal GABA transmission in the globus pallidus [74].

Underlining the existence of an endogenous adenosine tone reducing D2R signaling, A2AR antagonists KW 6002 and SCH 58261 induce reinstatement of cocaine seeking behavior in rats extinguished from cocaine self-administration. The mechanism is proposed to involve a blockade of the A2AR protomer of the neuronal A2AR-D2R heteroreceptor complex in the ventral striatopallidal GABA pathway. By altering the allosteric interactions in this A2AR-D2R heteroreceptor complex, the brake on D2R signaling is reduced and cocaine seeking can develop due to reduction of the glutamate drive to the prefrontal cortex [50]. In this way, it is possible that cognitive control including flexible goal-directed behavior probably becomes diminished and cocaine seeking develops. D2Rs are known to have a key role in cocaine use disorder [75, 76]. However, A2ARs appear to have a different role in the dorsal striatum where a striatum-specific A2AR deletion led to selective impairment of habit formation [77]. Later on, it was demonstrated that dorsomedial striatopallidal GABA neurons upon optogenetic activation of their A2ARs diminished goal-directed behavior [78]. Thus, in this circuit, A2AR signaling when linked to reward may favour habit formation.

It is clear, however, that A2AR agonists target both A2AR homo- and A2AR-D2R heteroreceptor complexes and that A2AR homoreceptor complexes can contribute to the anticocaine actions observed. There are at the moment no preferential A2AR agonists for the A2AR protomer of the A2AR-D2R heteroreceptor complex nor preferential antagonists for the D2R protomer of this complex. Multitargeting drugs with A2AR agonist [79] and D2R antagonist activities are promising molecules to combat cocaine use disorder.

Heterobivalent drugs are attractive novel drugs to be developed [8083]. In this case, they should be built based on an A2AR agonist pharmacophore linked to a D2R antagonist pharmacophore which should preferentially target A2AR-D2R heteroreceptor complexes with a high affinity and selectivity. Their selective action on neurons containing A2AR-D2R heteroreceptor complexes may predict less side effects. Previously, A2AR antagonist-D2R agonist bivalent compounds were proposed as tools to find A2AR-D2R receptor heteromers and as a novel strategy for treatment of Parkinson’s disease [84].

Small inhibitory interface peptides targeting the A2AR-D2R interface are also of interest as they may block the formation of the A2AR-D2R heteroreceptor complex or alter the heteroreceptor-mediated signaling [56]. Inhibitory interface peptides were first used in studies on D5R-GABA-A [23], D1R-NMDAR [22], and D2R-NR2B [24] heterocomplexes showing their physiological role. Competitive peptides were also used in determining the physiological role of A2AR-D2R heterodimerization in regulating NMDAR mediated excitation of neurons in the nucleus accumbens [85]. Furthermore, their use could help to unravel the role of the A2AR-D2R heteroreceptor complexes versus the A2AR homoreceptor complex in the actions of A2AR agonists on cocaine reward and cocaine seeking.

4.3. Allosteric A2AR-D2R Interactions in Cocaine Self-Administration

Previous work demonstrated that antagonistic allosteric A2AR-D2R interactions exist in the ventral and dorsal striatum of drug naïve control rats involving an A2AR induced reduction of the affinity of the high affinity D2R agonist binding site [47, 48]. It was therefore of high interest to study how maintenance of cocaine-self-administration affected this allosteric interaction in the ventral and dorsal striatum [16]. It was found that cocaine self-administration differentially affected the allosteric A2AR-D2R interactions in the ventral and dorsal striatum versus the yoked saline group.

The current protocol produces elevation of extracellular levels of DA in the nucleus accumbens in 2 h cocaine self-administration sessions [86] and no changes in the A2AR and D2R antagonist binding sites in the striatum were observed in terms of and values [87].

It was found that CGS 21680, the A2AR agonist, ex vivo using 3H-raclopride/quinpirole competition curves produced a significant reduction of the affinity of the D2-like high affinity receptor agonist binding site after cocaine self-administration in the ventral striatum versus the yoked saline group. The mechanism may involve a cocaine-induced change in the balance of A2AR-D2R heteroreceptor complexes versus A2AR homoreceptor complexes and other types of A2AR heteroreceptor complexes favouring an increase in A2AR-D2R heteroreceptor complexes. Such a change can contribute to the increase in the antagonistic allosteric A2AR-D2R interaction observed.

Our hypothesis is that changes in neuronal plasticity in cocaine self-administration may involve a reorganization of the balance of the A2AR monomers and homo/heteroreceptor complexes which can vary from one synapse to another and from one neuron to the other one. Several A2AR heteroreceptor complexes were already discussed and can be present at the pre- and/or postsynaptic level including the A2AR-D2R heteroreceptor complexes and together with other heteroreceptor complexes like the NMDAR heteroreceptor complexes [22, 24]. It should be noted that inactivation of A2ARs blocks long-term potentiation [88] and working memory deficits are reversed upon inactivation of A2ARs [89]. A2ARs can also form heterocomplexes with FGFR1 [25, 33].

Another mechanism may be that cocaine through its release of DA and/or indirect/direct allosteric enhancement of D2R signaling [90] can induce an allosteric feedback to help reduce D2R function via this antagonistic allosteric mechanism in the ventral striatum [16]. Thus, the anticocaine actions of A2AR agonists may at least in part be determined by the strength of the antagonistic allosteric A2AR-D2R interaction and the number of A2AR-D2R heteroreceptor complexes present, which leads to increased activity of the ventral striatopallidal GABA neurons representing an antireward system.

Dynamic changes also developed in the allosteric A2AR-D2R interactions in the dorsal striatum upon maintenance of cocaine self-administration. However, in this case, they resulted in disappearance of the antagonistic A2AR-D2R interaction found in yoked saline rats after ex vivo incubation of the membrane preparations with the A2AR agonist CGS 21680 [16]. As a consequence, no reduction of the affinity in the D2R high affinity agonist binding site was observed. Thus, the allosteric brake on the D2R protomer signaling in the A2AR-D2R heteroreceptor complex of the dorsal striatopallidal GABA neurons is lost upon cocaine self-administration. This is potentially due to differences in composition and allosteric plasticity of these complexes versus those in the ventral striatopallidal neurons. In line with these results, it was previously found that DA increased its potency to increase D2R Gi/o coupling in dorsal but not ventral striatal membranes in cocaine self-administration [87]. It is proposed that the disappearance of the allosteric brake on the D2R protomer signaling in the A2AR-D2R heteroreceptor complex can alter cocaine seeking, habit forming learning, and/or locomotor sensitization which remains to be determined.

In view of the allosteric theory of learning and memory based on the formation of a molecular engram built up of homo- and heteroreceptor complexes [12, 13], it is proposed that the loss of the allosteric A2AR-D2R interactions is caused by a reorganization or loss of the A2AR-D2R heteroreceptor complex. This leads to an alteration of the molecular engram in the synapses affected linked to a change in learning due to loss of the allosteric brake. The altered long-term memories formed are likely the basis for the novel habits formed versus goal-directed behavior. Neuronal plasticity induced by cocaine at the molecular level through allosteric mechanisms can therefore produce changes in the brain circuits involved. According to the work of Li et al. [78], increases in A2AR signaling should lead to suppression of goal-directed behavior. Therefore, the increased balance of A2AR and D2R signaling in the dorsomedial striatopallidal GABA neurons through loss of the inhibitory allosteric mechanism should reduce, if anything, the appearance of abnormal habit formation.

The hypothesis is advanced that the mechanism for the potential therapeutic actions of A2AR agonists in cocaine addiction is their ability to activate the A2AR brake on D2R protomer signaling in the ventral striatum even more strongly in this disease than in drug naïve controls. This action will markedly reduce the rewarding actions of cocaine through the activation of the antireward system. However, the A2AR protomer brake on the D2R protomer signaling in the dorsal striatum in contrast disappears upon prolonged cocaine use. Its impact on cocaine seeking behavior remains to be determined.

The mechanism for the differential effects observed on the allosteric A2AR-D2R interactions in the ventral versus the dorsal striatum in cocaine self-administration can depend on regional differences in the stoichiometry and composition of the A2AR-D2R heteroreceptor complexes [10, 11]. This could involve differential recruitment of adaptor proteins and other receptors to the heteroreceptor complex.

5. On the Existence of Sigma-1R-D2R and A2AR-D2R-Sigma-1R Heteroreceptor Complexes in the Ventral and Dorsal Striatum and Their Potential to Understand the Differential Allosteric A2AR-D2R Receptor-Receptor Interactions in These Regions

It is known that sigma-1R-D2R heteroreceptor complexes exist and form higher-order oligomers and are specific for D2Rs versus D3Rs and D4Rs [17]. Recently, it was shown with BRET analysis that sigma-1Rs form heteroreceptor complexes to the same degree with D2 short and long receptor isoforms [14, 15]. It is of substantial interest that the sigma-1R addition in increasing concentrations does not reduce the BRET signal obtained with either D2 short or D2 long isoforms in cell models. The explanation can be multiple interfaces for sigma-1R-D2R interactions; that is, the sigma-1R may bind to different regions of the D2R [15]. With in situ PLA, the sigma-1R-D2R heteroreceptor complexes were demonstrated within discrete regions of the dorsal and ventral striatum of the rat [14, 15]. The densities of complexes were substantially higher in the dorsal versus the ventral striatum [14, 15] and a selective cocaine-induced increase of the sigma1Rs was demonstrated in the ventral versus the dorsal striatum [18]. These results can help understand the differential effects on allosteric A2AR-D2R interactions observed upon cocaine self-administration in the ventral and dorsal striatum (see above). The mechanism may involve an increased presence of A2AR-D2R-sigma-1R heteroreceptor complexes in the ventral versus the dorsal striatum after cocaine self-administration (Figure 2).

Figure 2: ((a) Dorsal striatum) Yoked saline group. The high density of D2R-sigma1R [14, 15] leads to an increased formation of A2AR-D2R-sigma1R heterocomplexes which together with the A2AR-D2R heterocomplexes can be in dominance over D2 homoreceptor complexes. This can help explain the significant antagonistic A2AR-D2R interaction observed [16]. Cocaine self-administration (maintenance) group. Cocaine can bind to the sigma1R [17] but does not increase its recruitment to the plasma membrane in the dorsal striatum [18]. Instead, it is proposed that the major change induced by cocaine can be the increase in extracellular DA levels which is postulated to increase the formation of D2R homoreceptor complexes. Due to competition, this can reduce the number of A2AR-D2R and A2AR-D2R-sigma1R heteroreceptor complexes. As a result, the antagonistic allosteric A2AR-D2R interactions disappear [16]. ((b) Ventral striatum) Yoked saline group. The lower density of D2R-sigma-1R, especially in nuc accumbens core [14, 15], may lead to the preferential formation of D2R-sigma1R heterocomplexes in view of a possible higher affinity of sigma1R for D2R monomer-homoreceptor complexes versus the affinity for the A2AR-D2R heteroreceptor complexes. Due to competition, the A2AR-D2R heteroreceptor complexes will become reduced and only weak nonsignificant antagonistic A2AR-D2R interactions develop. Cocaine self-administration (maintenance) group. Upon cocaine self-administration, cocaine can here increase sigma1R expression [18] and increase its recruitment to the plasma membrane where it interacts with D2R potentially at several interfaces. In view of the marked increase of sigma1R in the plasma membrane increased formation of A2AR-D2R-sigma1R heteroreceptor complexes can develop with restoration of significant antagonistic A2AR-D2R interactions [16] in spite of increases in extracellular DA levels postulated to favour D2R homodimerization.

In relation to this hypothesis, there are novel data on the actions of cocaine at a low concentration on D2R signaling using CREB luciferase reporter gene assay in HEK293 cells. Cocaine (100 nM) increased the potency of D2R signaling when D2Rs and sigma-1Rs were expressed together [14]. Cocaine lacked effects when the D2Rs were expressed alone. Thus, cocaine at a low concentration can enhance the D2R mediated neurochemical effects like enhancement of Gi/o-mediated coupling but only in the sigma-1R-D2R heteroreceptor complex. These effects remained in the presence of DA transporter inhibitors and likely represented allosteric effects on the D2R protomers mediated via the sigma-1R in the heteroreceptor complex. In the absence of cocaine, a coexpression of D2Rs and sigma-1Rs show a reduced potency of D2R agonists to inhibit the CREB signal [14, 15]. It is of high interest that, even in the presence of 100 nM cocaine, CGS 21680 strongly reduced the potency of the D2R agonist to inhibit the CREB signal. This suggests the existence of a putative A2AR-D2R-sigma-1R heteroreceptor complex in HEK293 cells where the antagonistic A2AR-D2R interactions may be strongly enhanced. In this context, it is relevant to notice the partial overlap in the distribution of D2R-sigma1R and A2AR-D2R heteroreceptor complexes in the nucleus accumbens shell as found with in situ PLA [15].

In line with these results, it was found in HEK293 cells coexpressing sigma-1Rs and D2Rs that cocaine at 1 nM increased the values of plasma membrane D2Rs, an action blocked by the sigma-1R antagonist PD 144418. The mechanism for the increase in the values can involve a blockade of cocaine-induced D2R-YFP internalization when the sigma-1R forms a heteroreceptor complex with the D2R. This action was so far observed in the 1–100 nM range of cocaine [14, 15]. These results on cocaine actions in the nanomolar range on D2R-sigma-1R and on putative A2AR-D2R-sigma-1R heteroreceptor complexes are of high interest. They offer a new possibility to understand the differential effects of self-administered cocaine on the allosteric A2AR-D2R interactions in the dorsal versus the ventral striatum in the cocaine self-administration experiments (Figure 2).

It is proposed that the higher density of D2R/sigma-1R heterocomplexes in the dorsal versus the ventral striatum [14, 15] and selective cocaine-induced increases of the sigma-1Rs in the ventral striatum [18] contribute to the differential effects of self-administered cocaine on the A2AR-D2R interactions in the dorsal and ventral striatum, respectively (Figure 2). The sigma-1R is a molecular chaperone which inter alia assists in the translocation of receptors, especially D2Rs, to the plasma membrane through its binding to the receptor. It can also directly bind to the D2R in the plasma membrane [17, 91].

6. Conclusions

The current overview supports the hypothesis that the A2AR agonists represent novel drugs against cocaine use disorder because they inter alia can trigger the antagonistic allosteric A2AR-D2R interactions in A2AR-DR2 and A2AR-D2R-sigma-1R heteroreceptor complexes located in the ventral striatum. However, also A2AR homoreceptor complexes can participate as well as other types of A2AR heteroreceptor complexes like A2AR-mGlu5R and A2AR-mGlu5R-D2R heteroreceptor complexes [73, 92]. Such actions would result in increased activity in the ventral striatopallidal GABA antireward pathway thus leading to reward reversal and reduction of cocaine reinforcement in self-administration. The mechanism may in cocaine self-administration involve a differential reorganization of the A2AR-D2R, sigma-1R-D2R, and A2AR-D2R-sigma-1R heteroreceptor complexes and their balance with A2AR homoreceptor complexes and other types of A2AR heteroreceptor complexes in the ventral striatum as discussed above. It can lead to the differential dopaminergic signaling observed in the ventral and dorsal striatum with selective A2AR agonist induced inhibition of D2R signaling in the ventral striatum (Figure 2). The loss of the antagonistic allosteric A2AR-D2R interactions in the dorsal striatopallidal GABA neurons of the dorsal striatum found in cocaine self-stimulation can have an impact on novel habit formation versus goal-directed behavior that remains to be determined [78].

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this manuscript.

Acknowledgments

The work was supported by grants from the Swedish Medical Research Council (62X-00715-50-3) to Kjell Fuxe, by AFA Försäkring (130328) to Kjell Fuxe and Dasiel O. Borroto-Escuela, by Hjärnfonden to Dasiel O. Borroto-Escuela, and by the statutory funds of the Institute of Pharmacology Polish Academy of Sciences (Kraków, Poland) to Karolina Wydra, Magdalena Zaniewska, and Malgorzata Filip. Dasiel O. Borroto-Escuela belongs to Academia de Biólogos Cubanos.

References

  1. K. Fuxe, L. F. Agnati, F. Benfenati et al., “Evidence for the existence of receptor—receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides,” Journal of Neural Transmission, vol. 18, pp. 165–179, 1983. View at Google Scholar · View at Scopus
  2. K. Fuxe and L. F. Agnati, “Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses,” Medicinal Research Reviews, vol. 5, no. 4, pp. 441–482, 1985. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Zoli, L. F. Agnati, P. B. Hedlund, X. M. Li, S. Ferré, and K. Fuxe, “Receptor-receptor interactions as an integrative mechanism in nerve cells,” Molecular Neurobiology, vol. 7, no. 3-4, pp. 293–334, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Guo, E. Urizar, M. Kralikova et al., “Dopamine D2 receptors form higher order oligomers at physiological expression levels,” The EMBO Journal, vol. 27, no. 17, pp. 2293–2304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Han, I. S. Moreira, E. Urizar, H. Weinstein, and J. A. Javitch, “Allosteric communication between protomers of dopamine class a GPCR dimers modulates activation,” Nature Chemical Biology, vol. 5, no. 9, pp. 688–695, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Fuxe, D. Marcellino, D. Guidolin, A. S. Woods, and L. Agnati, “Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug Development,” JAMS Journal of Acupuncture and Meridian Studies, vol. 2, no. 1, pp. 1–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. R. George, A. Kern, R. G. Smith, and R. Franco, “Dopamine receptor heteromeric complexes and their emerging functions,” Progress in Brain Research, vol. 211, pp. 183–200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fuxe and D. O. Borroto-Escuela, “Heteroreceptor complexes and their allosteric receptor-receptor interactions as a novel biological principle for integration of communication in the CNS: targets for drug development,” Neuropsychopharmacology, vol. 41, no. 1, pp. 380–382, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. D. O. Borroto-Escuela, W. Romero-Fernandez, G. Mudó et al., “Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity,” Biological Psychiatry, vol. 71, no. 1, pp. 84–91, 2012. View at Publisher · View at Google Scholar
  10. D. O. Borroto-Escuela, B. Hagman, M. Woolfenden et al., “In situ proximity ligation assay to study and understand the distribution and balance of GPCR homo- and heteroreceptor complexes in the brain,” in Receptor and Ion Channel Detection in the Brain: Methods and Protocols, R. Luján and F. Ciruela, Eds., vol. 110 of Neuromethods, pp. 109–124, Springer, Berlin, Germany, 2016. View at Publisher · View at Google Scholar
  11. D. O. Borroto-Escuela, I. Brito, M. Di Palma, and K. Fuxe, “On the role of the balance of GPCR homo/heteroreceptor complexes in the brain,” Journal of Advanced Neuroscience Research, vol. 2, pp. 36–44, 2015. View at Google Scholar
  12. K. Fuxe, L. F. Agnati, and D. O. Borroto-Escuela, “The impact of receptor-receptor interactions in heteroreceptor complexes on brain plasticity,” Expert Review of Neurotherapeutics, vol. 14, no. 7, pp. 719–721, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Fuxe, D. O. Borroto-Escuela, F. Ciruela, D. Guidolin, and L. F. Agnati, “Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory,” Neuroscience Discovery, vol. 2, 2014. View at Publisher · View at Google Scholar
  14. L. Pinton, D. O. Borroto-Escuela, M. Narváez et al., “Dopamine D2 receptor dynamic and modulation in the D2R-Sigma1R heteroreceptor complexes: role in cocaine actions,” in European Neuropsychopharmacology, vol. 25, supplement 2, pp. S609–S610, Elsevier, 2015. View at Google Scholar
  15. L. Pinton, D. O. Borroto-Escuela, M. Narváez, J. Oflijan, L. F. Agnati, and K. Fuxe, “Evidence for the existence of dopamine D2R and Sigma 1 allosteric receptor-receptor interaction in the rat brain: role in brain plasticity and cocaine action,” European Society for Neurochemistry Biannual Conference: Molecular Mechanisms of Regulation in the Nervous System, vol. 4, supplement 1, p. P37, 2015. View at Publisher · View at Google Scholar
  16. J. Pintsuk, D. O. Borroto-Escuelaa, B. Pomierny et al., “Cocaine self-administration differentially affects allosteric A2A-D2 receptor-receptor interactions in the striatum. Relevance for cocaine use disorder,” Pharmacology, Biochemistry and Behavior, vol. 144, pp. 85–91, 2016. View at Publisher · View at Google Scholar
  17. G. Navarro, E. Moreno, J. Bonaventura et al., “Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers,” PLoS ONE, vol. 8, no. 4, Article ID e61245, 2013. View at Publisher · View at Google Scholar
  18. P. Romieu, V.-L. Phan, R. Martin-Fardon, and T. Maurice, “Involvement of the sigma1 receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade,” Neuropsychopharmacology, vol. 26, no. 4, pp. 444–455, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Fuxe, A. Tarakanov, W. Romero Fernandez et al., “Diversity and bias through receptor-receptor interactions in GPCR heteroreceptor complexes. Focus on examples from dopamine D2 receptor heteromerization,” Frontiers in Endocrinology, vol. 5, article 71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. O. Borroto-Escuela, A. O. Tarakanov, D. Guidolin, F. Ciruela, L. F. Agnati, and K. Fuxe, “Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration,” IUBMB Life, vol. 63, no. 7, pp. 463–472, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Filip, M. Zaniewska, M. Frankowska, K. Wydra, and K. Fuxe, “The importance of the adenosine A2A receptor-dopamine D2 receptor interaction in drug addiction,” Current Medicinal Chemistry, vol. 19, no. 3, pp. 317–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. F. J. S. Lee, S. Xue, L. Pei et al., “Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor,” Cell, vol. 111, no. 2, pp. 219–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Liu, Q. Wan, Z. B. Pristupa, X.-M. Yu, Y. T. Wang, and H. B. Niznik, “Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors,” Nature, vol. 403, no. 6767, pp. 274–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-Y. Liu, X.-P. Chu, L.-M. Mao et al., “Modulation of D2R-NR2B interactions in response to cocaine,” Neuron, vol. 52, no. 5, pp. 897–909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Flajolet, Z. Wang, M. Futter et al., “FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity,” Nature Neuroscience, vol. 11, no. 12, pp. 1402–1409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. O. Borroto-Escuela, F. Corrales, M. Narvaez et al., “Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2,” Biochemical and Biophysical Research Communications, vol. 441, no. 2, pp. 387–392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. O. Borroto-Escuela, M. Narvaez, M. Pérez-Alea et al., “Evidence for the existence of FGFR1-5-HT1A heteroreceptor complexes in the midbrain raphe 5-HT system,” Biochemical and Biophysical Research Communications, vol. 456, no. 1, pp. 489–493, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. D. O. Borroto-Escuela, M. Pérez-Alea, M. Narvaez et al., “Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression,” Biochemical and Biophysical Research Communications, vol. 463, no. 3, pp. 180–186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Fuxe, A. Dahlström, M. Höistad et al., “From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission,” Brain Research Reviews, vol. 55, no. 1, pp. 17–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Fuxe, D. O. Borroto-Escuela, A. Tarakanov et al., “Understanding the balance and integration of volume and synaptic transmission. Relevance for psychiatry,” Neurology Psychiatry and Brain Research, vol. 19, no. 4, pp. 141–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. D. O. Borroto-Escuela, L. F. Agnati, K. Bechter, A. Jansson, A. O. Tarakanov, and K. Fuxe, “The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural-glial networks,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, no. 1672, pp. 1–14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. D. O. Borroto-Escuela, A. O. Tarakanov, and K. Fuxe, “FGFR1-5-HT1A heteroreceptor complexes: implications for understanding and treating major depression,” Trends in Neurosciences, vol. 39, no. 1, pp. 5–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. D. O. Borroto-Escuela, M. Flajolet, L. F. Agnati, P. Greengard, and K. Fuxe, “Bioluminescence resonance energy transfer methods to study g protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes,” Methods in Cell Biology, vol. 117, pp. 141–164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. D. O. Borroto-Escuela, W. Romero-Fernandez, P. Garriga et al., “G protein-coupled receptor heterodimerization in the Brain,” Methods in Enzymology, vol. 521, pp. 281–294, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. D. D. Jensen, C. B. Godfrey, C. Niklas et al., “The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts,” The Journal of Biological Chemistry, vol. 288, no. 32, pp. 22942–22960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Mandić, L. Drinovec, S. Glisic, N. Veljkovic, J. Nøhr, and M. Vrecl, “Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics,” PloS ONE, vol. 9, no. 11, Article ID e112664, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Wiese, S. Jablonka, B. Holtmann et al., “Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17210–17215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Assaife-Lopes, V. C. Sousa, D. B. Pereira, J. A. Ribeiro, and A. M. Sebastião, “Regulation of TrkB receptor translocation to lipid rafts by adenosine A(2A) receptors and its functional implications for BDNF-induced regulation of synaptic plasticity,” Purinergic signalling, vol. 10, no. 2, pp. 251–267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. R. D. Hawkins, E. R. Kandel, and S. A. Siegelbaum, “Learning to modulate transmitter release: themes and variations in synaptic plasticity,” Annual Review of Neuroscience, vol. 16, pp. 625–665, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-P. Vilardaga, L. F. Agnati, K. Fuxe, and F. Ciruela, “G-protein-coupled receptor heteromer dynamics,” Journal of Cell Science, vol. 123, no. 24, pp. 4215–4220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. D. O. Borroto-Escuela, A. Ravani, A. O. Tarakanov et al., “Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers,” Biochemical and Biophysical Research Communications, vol. 435, no. 1, pp. 140–146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Herrick-Davis, E. Grinde, T. Lindsley, A. Cowan, and J. E. Mazurkiewicz, “Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers,” Journal of Biological Chemistry, vol. 287, no. 28, pp. 23604–23614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. R. S. Kasai and A. Kusumi, “Single-molecule imaging revealed dynamic GPCR dimerization,” Current Opinion in Cell Biology, vol. 27, no. 1, pp. 78–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. R. S. Kasai, K. G. N. Suzuki, E. R. Prossnitz et al., “Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging,” Journal of Cell Biology, vol. 192, no. 3, pp. 463–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Mondal, G. Khelashvili, N. Johner, and H. Weinstein, “How the dynamic properties and functional mechanisms of GPCRs are modulated by their coupling to the membrane environment,” Advances in Experimental Medicine and Biology, vol. 796, pp. 55–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. R. J. Ward, J. D. Pediani, A. G. Godin, and G. Milligan, “Regulation of oligomeric organization of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor observed by spatial intensity distribution analysis,” The Journal of Biological Chemistry, vol. 290, no. 20, pp. 12844–12857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Fuxe, S. Ferré, M. Zoli, and L. F. Agnati, “Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia,” Brain Research Reviews, vol. 26, no. 2-3, pp. 258–273, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Díaz-Cabiale, Y. Hurd, D. Guidolin et al., “Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum,” NeuroReport, vol. 12, no. 9, pp. 1831–1834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Hillion, M. Canals, M. Torvinen et al., “Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors,” The Journal of Biological Chemistry, vol. 277, no. 20, pp. 18091–18097, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Fuxe, D. Marcellino, A. Rivera et al., “Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology,” Brain Research Reviews, vol. 58, no. 2, pp. 415–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. D. O. Borroto-Escuela, W. Romero-Fernandez, A. O. Tarakanov, F. Ciruela, L. F. Agnati, and K. Fuxe, “On the existence of a possible A2A-D2-β- arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment,” Journal of Molecular Biology, vol. 406, no. 5, pp. 687–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Rimondini, S. Ferre, S. O. Ogren, and K. Fuxe, “Adenosine A2A agonists: a potential new type of atypical antipsychotic,” Neuropsychopharmacology, vol. 17, no. 2, pp. 82–91, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. D. O. Borroto-Escuela, D. Marcellino, M. Narvaez et al., “A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R,” Biochemical and Biophysical Research Communications, vol. 394, no. 1, pp. 222–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Ciruela, J. Burgueño, V. Casadó et al., “Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors,” Analytical Chemistry, vol. 76, no. 18, pp. 5354–5363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. A. S. Woods, F. Ciruela, K. Fuxe et al., “Role of electrostatic interaction in receptor-receptor heteromerization,” Journal of Molecular Neuroscience, vol. 26, no. 2-3, pp. 125–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. D. O. Borroto-Escuela, W. Romero-Fernandez, A. O. Tarakanov et al., “Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices,” Biochemical and Biophysical Research Communications, vol. 402, no. 4, pp. 801–807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. A. O. Tarakanov and K. G. Fuxe, “Triplet puzzle: homologies of receptor heteromers,” Journal of Molecular Neuroscience, vol. 41, no. 2, pp. 294–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. D. O. Borroto-Escuela, I. Brito, W. Romero-Fernandez et al., “The G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub components,” International Journal of Molecular Sciences, vol. 15, no. 5, pp. 8570–8590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Trifilieff, M.-L. Rives, E. Urizar et al., “Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum,” BioTechniques, vol. 51, no. 2, pp. 111–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. K. Lobo, H. E. Covington III, D. Chaudhury et al., “Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward,” Science, vol. 330, no. 6002, pp. 385–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. M. Kupchik, R. M. Brown, J. A. Heinsbroek, M. K. Lobo, D. J. Schwartz, and P. W. Kalivas, “Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections,” Nature Neuroscience, vol. 18, no. 9, pp. 1230–1232, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. M. T. Tebano, A. Martire, R. L. Potenza et al., “Adenosine A2A receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus,” Journal of Neurochemistry, vol. 104, no. 1, pp. 279–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Wydra, K. Gołembiowska, A. Suder, K. Kamińska, K. Fuxe, and M. Filip, “On the role of adenosine A2A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats,” Psychopharmacology, vol. 232, no. 2, pp. 421–435, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. C. M. Knapp, M. M. Foye, N. Cottam, D. A. Ciraulo, and C. Kornetsky, “Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration,” Pharmacology Biochemistry and Behavior, vol. 68, no. 4, pp. 797–803, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Wydra, A. Suder, D. O. Borroto-Escuela, M. Filip, and K. Fuxe, “On the role of A2A and D2 receptors in control of cocaine and food-seeking behaviors in rats,” Psychopharmacology, vol. 232, no. 10, pp. 1767–1778, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Wydra, K. Gołembiowska, A. Suder, K. Kamińska, K. Fuxe, and M. Filip, “On the role of adenosine (A)2A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats,” Psychopharmacology, vol. 232, no. 2, pp. 421–435, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. C. E. O'Neill, M. L. Letendre, and R. K. Bachtell, “Adenosine A2A receptors in the nucleus accumbens Bi-directionally alter cocaine seeking in rats,” Neuropsychopharmacology, vol. 37, no. 5, pp. 1245–1256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Ciruela, V. Casadó, R. J. Rodrigues et al., “Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers,” Journal of Neuroscience, vol. 26, no. 7, pp. 2080–2087, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Cabello, J. Gandía, D. C. G. Bertarelli et al., “Metabotropic glutamate type 5, dopamine D2 and adenosine A 2a receptors form higher-order oligomers in living cells,” Journal of Neurochemistry, vol. 109, no. 5, pp. 1497–1507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ferré, M. Karcz-Kubicha, B. T. Hope et al., “Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11940–11945, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Popoli, A. Pèzzola, M. Torvinen et al., “The selective mGlu5 receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D2 receptors in the rat striatum: interactions with adenosine A2a receptors,” Neuropsychopharmacology, vol. 25, no. 4, pp. 505–513, 2001. View at Publisher · View at Google Scholar
  72. R. J. Rodrigues, T. M. Alfaro, N. Rebola, C. R. Oliveira, and R. A. Cunha, “Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum,” Journal of Neurochemistry, vol. 92, no. 3, pp. 433–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. H.-Y. Shen, P. M. Canas, P. Garcia-Sanz et al., “Adenosine a2A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation,” PLoS ONE, vol. 8, no. 11, article e80902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Shindou, H. Nonaka, P. J. Richardson, A. Mori, H. Kase, and M. Ichimura, “Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus,” British Journal of Pharmacology, vol. 136, no. 2, pp. 296–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. G. F. Koob, “Negative reinforcement in drug addiction: the darkness within,” Current Opinion in Neurobiology, vol. 23, no. 4, pp. 559–563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. B. J. Everitt and U. Heberlein, “Addiction,” Current Opinion in Neurobiology, vol. 23, no. 4, pp. 463–466, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Yu, J. Gupta, J.-F. Chen, and H. H. Yin, “Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation,” The Journal of Neuroscience, vol. 29, no. 48, pp. 15100–15103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Li, Y. He, M. Chen et al., “Optogenetic activation of adenosine A2A receptor signaling in the dorsomedial striatopallidal neurons suppresses goal-directed behavior,” Neuropsychopharmacology, vol. 41, no. 4, pp. 1003–1013, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Gutierrez-de-Teran, J. Sallander, and E. Sotelo, “Structure-based rational design of adenosine receptor ligands,” Current Topics in Medicinal Chemistry, vol. 16, no. 30, 2016. View at Publisher · View at Google Scholar
  80. A. S. Yekkirala, A. E. Kalyuzhny, and P. S. Portoghese, “An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligands,” ACS Chemical Biology, vol. 8, no. 7, pp. 1412–1416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. B. A. Smeester, M. M. Lunzer, E. Akgün, A. J. Beitz, and P. S. Portoghese, “Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model,” European Journal of Pharmacology, vol. 743, pp. 48–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. P. S. Portoghese, “From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes,” Journal of Medicinal Chemistry, vol. 44, no. 14, pp. 2259–2269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Le Naour, E. Akgün, A. Yekkirala et al., “Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance,” Journal of Medicinal Chemistry, vol. 56, no. 13, pp. 5505–5513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Soriano, R. Ventura, A. Molero et al., “Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A 2A-D2 receptor heteromers,” Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5590–5602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Azdad, D. Gall, A. S. Woods, C. Ledent, S. Ferré, and S. N. Schiffmann, “Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A–D2 receptor heteromerization,” Neuropsychopharmacology, vol. 34, no. 4, pp. 972–986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Wydra, K. Golembiowska, M. Zaniewska et al., “Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats,” Addiction Biology, vol. 18, no. 2, pp. 307–324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Frankowska, D. Marcellino, P. Adamczyk, M. Filip, and K. Fuxe, “Effects of cocaine self-administration and extinction on D2-like and A2A receptor recognition and D2-like/Gi protein coupling in rat striatum,” Addiction Biology, vol. 18, no. 3, pp. 455–466, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. P. D'Alcantara, C. Ledent, S. Swillens, and S. N. Schiffmann, “Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission,” Neuroscience, vol. 107, no. 3, pp. 455–464, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. W. Li, H. B. Silva, J. Real et al., “Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models,” Neurobiology of Disease, vol. 79, pp. 70–80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. L. Ferraro, M. Frankowska, D. Marcellino et al., “A novel mechanism of cocaine to enhance dopamine D2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study,” Neuropsychopharmacology, vol. 37, no. 8, pp. 1856–1866, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Pabba, “The essential roles of protein-protein interaction in sigma-1 receptor functions,” Frontiers in Cellular Neuroscience, vol. 7, article 50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Beggiato, M. C. Tomasini, A. C. Borelli et al., “Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission,” Journal of Neurochemistry, vol. 138, no. 2, pp. 254–264, 2016. View at Publisher · View at Google Scholar